Newly synthesized N-cadherin is subsequently translocated to cellular membrane where it interacts with some growth factor receptors to activate their downstream signaling pathways, contributing to tumorigenesis including thyroid cancer. The gene discussed is CDH2; the disease is thyroid gland carcinoma.